Alliancebernstein L.P. Abbott Laboratories Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Alliancebernstein L.P. holds 4,152,101 shares of ABT stock, worth $431 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,152,101

Previous 9,490,059 56.25%

Holding current value

$431 Million

Previous $1.04 Billion 54.82%

% of portfolio

0.17%

Previous 0.41%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $585 Million - $646 Million	-5,337,958 Reduced 56.25%	4,152,101 $472 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $126 Million - $154 Million	-1,392,719 Reduced 12.8%	9,490,059 $1.04 Billion
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $68.8 Million - $82.5 Million	720,015 Added 7.08%	10,882,778 $1.05 Billion
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $91.9 Million - $102 Million	911,942 Added 9.86%	10,162,763 $1.11 Billion
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $3.48 Million - $4.09 Million	-35,907 Reduced 0.39%	9,250,821 $937 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $275 Million - $323 Million	-2,895,139 Reduced 23.77%	9,286,728 $1.02 Billion
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $9.35 Million - $10.8 Million	-96,668 Reduced 0.79%	12,181,867 $1.18 Billion
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $60.3 Million - $72.9 Million	-590,755 Reduced 4.59%	12,278,535 $1.33 Billion
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $77 Million - $93.9 Million	-675,329 Reduced 4.99%	12,869,290 $1.52 Billion
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $9.8 Million - $12 Million	-84,807 Reduced 0.62%	13,544,619 $1.91 Billion
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $75.5 Million - $83.5 Million	646,920 Added 4.98%	13,629,426 $1.61 Billion
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $8.92 Million - $10.5 Million	84,274 Added 0.65%	12,982,506 $1.51 Billion
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $48.8 Million - $57.4 Million	-448,021 Reduced 3.36%	12,898,232 $1.55 Billion
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $17.5 Million - $19 Million	166,232 Added 1.26%	13,346,253 $1.46 Billion
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $52.7 Million - $63.9 Million	574,569 Added 4.56%	13,180,021 $1.43 Billion
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $9.07 Million - $11.6 Million	118,392 Added 0.95%	12,605,452 $1.15 Billion
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $99.6 Million - $146 Million	-1,585,315 Reduced 11.27%	12,487,060 $985 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $47.9 Million - $53.3 Million	610,015 Added 4.53%	14,072,375 $1.22 Billion
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $65 Million - $70.5 Million	-794,033 Reduced 5.57%	13,462,360 $1.13 Billion
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $27.3 Million - $31.8 Million	374,235 Added 2.7%	14,256,393 $1.2 Billion
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $22.7 Million - $27.5 Million	-343,072 Reduced 2.41%	13,882,158 $1.11 Billion
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $10.8 Million - $12.2 Million	-163,999 Reduced 1.14%	14,225,230 $1.03 Billion
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $70.8 Million - $85.4 Million	-1,163,653 Reduced 7.48%	14,389,229 $1.06 Billion
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $51 Million - $56.3 Million	886,585 Added 6.05%	15,552,882 $949 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $124 Million - $140 Million	2,203,794 Added 17.68%	14,666,297 $879 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $5.42 Million - $5.81 Million	-101,061 Reduced 0.8%	12,462,503 $711 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $604 Million - $674 Million	12,563,564	12,563,564 $670 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Abbott Laboratories Transaction History